Janux Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer (NCT07545811) | Janux Therapeutics | 2026-04-15 |
| Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability. (NCT07291323) | Janux Therapeutics | 2026-02-16 |
| Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies (NCT05783622) | Janux Therapeutics | 2023-04-19 |
| Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) (NCT05519449) | Janux Therapeutics | 2022-09-15 |
Track Janux Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.